Learn More
Description
This compound disrupts actin microfilaments and activates the p53-dependent pathways, causing arrest of the cell cycle at the G1-S transition.
- Inhibits smooth muscle contraction
- Inhibits insulin-stimulated, but not basal, transport of glucose
- Possesses antibiotic and antitumor activity
- Impairs maintenance of long term potentiation (LTP) of actin filaments
- Implicated in promoting conditions favorable for depolymerizing actin
Specifications
Specifications
| Melting Point | 193°C to 195°C (literature) |
| Quantity | 10 mg |
| Solubility Information | Soluble in chloroform (10g/mL, clear, colorless solution), CH2Cl2 (10mg/ mL, clear colorless solution), DMSO and ethanol. |
| Formula Weight | 507.6 |
| Physical Form | Powder |
Safety and Handling
| Recommended Storage | Store at −20°C, protect from light, dessicated. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.